Approval · Notice of Compliance 7217 · 2005
TRELSTAR: Notice of Compliance 7217
Issued July 6, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7217
- Date
- July 6, 2005
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Luteinizing hormone-releasing hormone (lhrh) analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRELSTAR | 02240000 | Marketed |
| TRELSTAR LA | 02243856 | Marketed |
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per VIAL
- TRIPTORELIN PAMOATE 11.25 MG per VIAL